Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Colleen Kusy is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/28/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $38.90 | 157.07% | $100 → $100 | Maintains | Outperform | Get Alert |
| 06/11/2024 | OCS | Buy Now | Oculis Holding | $12.36 | 199.35% | $35 → $37 | Maintains | Outperform | Get Alert |
| 06/11/2024 | ELVN | Buy Now | Enliven Therapeutics | $23.37 | 36.93% | → $32 | Initiates | → Outperform | Get Alert |
| 05/02/2024 | SYRE | Buy Now | Spyre Therapeutics | $23.51 | 112.68% | → $50 | Initiates | → Outperform | Get Alert |
| 03/19/2024 | OCS | Buy Now | Oculis Holding | $12.36 | 183.17% | $64 → $35 | Maintains | Outperform | Get Alert |
| 03/12/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.07 | 253.61% | $27 → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 02/29/2024 | MRSN | Buy Now | Mersana Therapeutics | $2.01 | 148.76% | $1 → $5 | Maintains | Neutral | Get Alert |
| 02/23/2024 | NUVL | Buy Now | Nuvalent | $75.86 | 38.41% | → $105 | Initiates | → Outperform | Get Alert |
| 02/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $38.90 | 108.23% | → $81 | Reiterates | Outperform → Outperform | Get Alert |
| 01/23/2024 | CHRS | Buy Now | Coherus BioSciences | $1.73 | 420.23% | $11 → $9 | Maintains | Outperform | Get Alert |
| 01/17/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $38.90 | 108.23% | $71 → $81 | Maintains | Outperform | Get Alert |
| 11/17/2023 | CHRS | Buy Now | Coherus BioSciences | $1.73 | 535.84% | → $11 | Initiates | → Outperform | Get Alert |
| 09/14/2023 | OCUL | Buy Now | Ocular Therapeutix | $6.84 | 163.16% | → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 08/01/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $38.90 | 79.95% | $115 → $70 | Maintains | Outperform | Get Alert |
| 07/28/2023 | MRSN | Buy Now | Mersana Therapeutics | $2.01 | -50.25% | $7 → $1 | Downgrade | Outperform → Neutral | Get Alert |
| 06/20/2023 | SURF | Buy Now | Surface Oncology | — | — | — | Downgrade | Outperform → Neutral | Get Alert |
| 06/13/2023 | OCUL | Buy Now | Ocular Therapeutix | $6.84 | 75.44% | $10 → $12 | Maintains | Outperform | Get Alert |
| 06/08/2023 | OCS | Buy Now | Oculis Holding | $12.36 | 369.26% | → $58 | Initiates | → Outperform | Get Alert |
| 06/06/2023 | AGEN | Buy Now | Agenus | $16.80 | -52.38% | → $160 | Initiates | → Outperform | Get Alert |
| 05/04/2023 | SURF | Buy Now | Surface Oncology | — | — | → $6 | Maintains | Outperform | Get Alert |
| 05/04/2023 | ISEE | Buy Now | IVERIC bio | — | — | → $40 | Downgrade | Outperform → Neutral | Get Alert |
| 04/21/2023 | OCUL | Buy Now | Ocular Therapeutix | $6.84 | 163.16% | → $18 | Initiates | → Outperform | Get Alert |
| 02/21/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $38.90 | 169.92% | $90 → $105 | Maintains | Outperform | Get Alert |
| 11/15/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | — | Downgrade | Outperform → Neutral | Get Alert |
| 11/03/2022 | SURF | Buy Now | Surface Oncology | — | — | $11 → $6 | Maintains | Outperform | Get Alert |
| 10/19/2022 | AVEO | Buy Now | AVEO Pharmaceuticals | — | — | $17 → $15 | Downgrade | Outperform → Neutral | Get Alert |
| 09/07/2022 | ISEE | Buy Now | IVERIC bio | — | — | $27 → $34 | Maintains | Outperform | Get Alert |
| 08/09/2022 | MRSN | Buy Now | Mersana Therapeutics | $2.01 | 895.02% | $18 → $20 | Maintains | Outperform | Get Alert |
| 08/05/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $0.87 | 1509.2% | $17 → $14 | Maintains | Outperform | Get Alert |
| 08/03/2022 | SURF | Buy Now | Surface Oncology | — | — | $11 → $11 | Maintains | Outperform | Get Alert |
| 05/09/2022 | SURF | Buy Now | Surface Oncology | — | — | $11 → $11 | Maintains | Outperform | Get Alert |
| 04/13/2022 | SURF | Buy Now | Surface Oncology | — | — | → $11 | Maintains | Outperform | Get Alert |
| 04/07/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $8.07 | 321.31% | $30 → $34 | Maintains | Outperform | Get Alert |
| 03/03/2022 | ISEE | Buy Now | IVERIC bio | — | — | → $27 | Initiates | → Outperform | Get Alert |
| 02/25/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $8.07 | 271.75% | $35 → $30 | Maintains | Outperform | Get Alert |
| 11/02/2021 | SABS | Buy Now | SAB Biotherapeutics | $3.10 | 641.94% | → $230 | Initiates | → Outperform | Get Alert |
